series-c-plus
Stage
1
Investors
About
MacroGenics is a clinical-stage biopharmaceutical company developing monoclonal and bispecific antibody therapeutics primarily for oncology and immune-mediated diseases. It discovers and advances targeted antibody programs through clinical development toward potential commercialization.
Explore MacroGenics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.